Literature DB >> 8553583

Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.

K Mossman1, P Nation, J Macen, M Garbutt, A Lucas, G McFadden.   

Abstract

Myxoma virus is a leporipoxvirus of New World rabbits (Sylvilagus sp.) that induces a rapidly lethal infection known as myxomatosis in the European rabbit (Oryctolagus cuniculus). Like all poxviruses, myxoma virus encodes a plethora of proteins to circumvent or inhibit a variety of host antiviral immune mechanisms. M-T7, the most abundantly secreted protein of myxoma virus-infected cells, was originally identified as an interferon-gamma receptor homolog (Upton, Mossman, and McFadden, Science 258, 1369-1372, 1992). Here, we demonstrate that M-T7 is dispensable for virus replication in cultured cells but is a critical virulence factor for virus pathogenesis in European rabbits. Disruption of both copies of the M-T7 gene in myxoma virus was achieved by the deletion of 372 bp of M-T7 coding sequences, replacement with a selectable marker, p7.5Ecogpt, and selection of a recombinant virus (vMyxlac-T7gpt) resistant to mycophenolic acid. vMyxlac-T7gpt expressed no detectable M-T7 protein and infected cells supernatants were devoid of any detectable interferon-gamma binding activities. Immunohistochemical staining with anti-beta-galactosidase and anti-CD43 antibodies demonstrated that in vMyxlac-T7gpt-infected rabbits the loss of M-T7 not only caused a dramatic reduction in disease symptoms and viral dissemination to secondary sites, but also dramatically influenced host leukocyte behavior. Notably, primary lesions in wild-type virus infections were generally underlayed by large masses of inflammatory cells that did not effectively migrate into the dermal sites of viral replication, whereas in vMyxlac-T7gpt infections this apparent block to leukocyte influx was relieved. A second major phenotypic distinction noted for the M-T7 knockout virus was the extensive activation of lymphocytes in secondary immune organs, particularly the spleen and lymph nodes, by Day 4 of the infection. This is in stark contrast to infection by wild-type myxoma virus, which results in relatively little, if any, cellular activation of germinal centers of spleen and lymph node by Day 4. We conclude that M-T7 functions early in infection to (1) retard inflammatory cell migration into infected tissues and (2) disrupt the communication between sentinel immune cells at the site of primary virus infection in the subdermis and lymphocytes in the secondary lymphoid organs, thereby disabling the host from mounting an effective cellular immune response. To summarize, in addition to neutralizing host interferon-gamma at infected sites, we propose that M-T7 protein also modifies leukocyte traffic in the vicinity of virus lesions, thus effectively severing the link between antigen presenting cells of the infected tissue and the effector lymphocytes of the peripheral immune organs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8553583     DOI: 10.1006/viro.1996.0003

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  30 in total

1.  Viral antichemokines: from pathogenesis to drug discovery.

Authors:  P M Murphy
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

2.  Critical role for a high-affinity chemokine-binding protein in gamma-herpesvirus-induced lethal meningitis.

Authors:  Victor van Berkel; Beth Levine; Sharookh B Kapadia; James E Goldman; Samuel H Speck; Herbert W Virgin
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

3.  Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection.

Authors:  Isaac G Sakala; Geeta Chaudhri; R Mark Buller; Anthony A Nuara; Hongdong Bai; Nanhai Chen; Gunasegaran Karupiah
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

4.  Myxoma virus M156 is a specific inhibitor of rabbit PKR but contains a loss-of-function mutation in Australian virus isolates.

Authors:  Chen Peng; Sherry L Haller; Masmudur M Rahman; Grant McFadden; Stefan Rothenburg
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-22       Impact factor: 11.205

5.  Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition.

Authors:  M Schreiber; L Sedger; G McFadden
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

6.  Mutations in active-site residues of the uracil-DNA glycosylase encoded by vaccinia virus are incompatible with virus viability.

Authors:  K S Ellison; W Peng; G McFadden
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines.

Authors:  A S Lalani; K Graham; K Mossman; K Rajarathnam; I Clark-Lewis; D Kelvin; G McFadden
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

Review 8.  Viral Hormones: Expanding Dimensions in Endocrinology.

Authors:  Qian Huang; C Ronald Kahn; Emrah Altindis
Journal:  Endocrinology       Date:  2019-09-01       Impact factor: 4.736

9.  Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation.

Authors:  P Najarro; P Traktman; J A Lewis
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

10.  Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection.

Authors:  Erbin Dai; Li-Ying Liu; Hao Wang; Dana McIvor; Yun Ming Sun; Colin Macaulay; Elaine King; Ganesh Munuswamy-Ramanujam; Mee Yong Bartee; Jennifer Williams; Jennifer Davids; Israel Charo; Grant McFadden; Jeffrey D Esko; Alexandra R Lucas
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.